Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LCZ696 vs Olmesartan in Essential Hypertension
NCT01876368Phase 3Completed
- Sponsor
- Novartis
- Start
- Sep 2013
- Primary completion
- Aug 2014
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 3 trial of sacubitril + valsartan in essential hypertension, sponsored by Novartis. Started Sep 2013; status: completed.
02
Drugs
sacubitril + valsartan
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT01876368.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01876368.